Watson Acquires Andrx Despite OAI Hold Status
The $1.9 bil. acquisition will create the third largest generic pharmaceutical company in the U.S, Watson said March 13.
The $1.9 bil. acquisition will create the third largest generic pharmaceutical company in the U.S, Watson said March 13.